AU2002217832A1 - Black tea extract for prevention of disease - Google Patents

Black tea extract for prevention of disease

Info

Publication number
AU2002217832A1
AU2002217832A1 AU2002217832A AU1783202A AU2002217832A1 AU 2002217832 A1 AU2002217832 A1 AU 2002217832A1 AU 2002217832 A AU2002217832 A AU 2002217832A AU 1783202 A AU1783202 A AU 1783202A AU 2002217832 A1 AU2002217832 A1 AU 2002217832A1
Authority
AU
Australia
Prior art keywords
disease
prevention
tea extract
black tea
black
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217832A
Inventor
Kuang Yu Chen
Geetha Ghai
Chi-Tang Ho
Robert T. Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of AU2002217832A1 publication Critical patent/AU2002217832A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002217832A 2000-11-15 2001-11-14 Black tea extract for prevention of disease Abandoned AU2002217832A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24894200P 2000-11-15 2000-11-15
US60/248,942 2000-11-15
PCT/US2001/043931 WO2002039956A2 (en) 2000-11-15 2001-11-14 Black tea extract for prevention of disease

Publications (1)

Publication Number Publication Date
AU2002217832A1 true AU2002217832A1 (en) 2002-05-27

Family

ID=22941359

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217832A Abandoned AU2002217832A1 (en) 2000-11-15 2001-11-14 Black tea extract for prevention of disease

Country Status (5)

Country Link
US (2) US20020146472A1 (en)
EP (1) EP1349560B1 (en)
AU (1) AU2002217832A1 (en)
CA (1) CA2431196C (en)
WO (1) WO2002039956A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60304718T2 (en) 2002-08-06 2007-04-26 Astrazeneca Ab CONDENSED PYRIDINES AND PYRIMIDINES WITH TIE2 (TEK) ACTIVITY
US7977049B2 (en) * 2002-08-09 2011-07-12 President And Fellows Of Harvard College Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
JP2007530417A (en) 2003-07-01 2007-11-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Composition for manipulating the longevity and stress response of cells and organisms
US7758903B2 (en) 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
US7758902B2 (en) * 2003-09-12 2010-07-20 Access Business Group International Llc Cytokine modulators and related methods of use
JP4903569B2 (en) * 2003-09-12 2012-03-28 アクセス ビジネス グループ インターナショナル エルエルシー Cytokine modulators and related uses
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
JP2007527418A (en) 2003-12-29 2007-09-27 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Composition for treating or preventing obesity and insulin resistance disorders
SG150510A1 (en) * 2004-02-17 2009-03-30 Suntory Ltd Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same
US7351739B2 (en) 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
ES2614410T3 (en) * 2004-07-05 2017-05-31 Suntory Holdings Limited Lipase inhibitors
AU2006249771A1 (en) * 2005-05-24 2006-11-30 Wellgen, Inc. Compositions and methods for the prevention and treatment of conditions associated with inflammation
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
US7989009B2 (en) * 2006-02-02 2011-08-02 Advocare International, L.P. Composition and method for promoting weight loss
US20070178176A1 (en) * 2006-02-02 2007-08-02 Chithan Kandaswami Composition and method for promoting weight loss
CN101096693B (en) * 2007-07-26 2010-04-21 桂林莱茵生物科技股份有限公司 Method for preparing theaflavin and thearubigin from fresh green tea
PT2192844E (en) * 2007-09-28 2011-03-16 Unilever Nv Process for extracting theaflavins from tea
WO2009117145A1 (en) 2008-03-21 2009-09-24 Rutgers, The State University Of New Jersey Use of tea-derived, theaflavin enriched extract to increase exercise performance and reduce exercise recovery time
JP5424424B2 (en) * 2011-10-03 2014-02-26 国立大学法人 鹿児島大学 Anti-inflammatory agent or food and drink having anti-inflammatory effect
WO2014074753A1 (en) * 2012-11-09 2014-05-15 XIAOWEI, Shi Oral care composition containing theaflavin extract
WO2020218755A1 (en) * 2019-04-25 2020-10-29 ㈜아모레퍼시픽 Composition for promoting adipocyte differentiation comprising theaflavin
KR102359446B1 (en) * 2019-04-25 2022-02-09 (주)아모레퍼시픽 Composition comprising theaflavin for promoting differentiation of adipocyte

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4880710A (en) * 1972-01-27 1973-10-29
JPS6025933A (en) * 1983-07-22 1985-02-08 Tsumura Juntendo Inc Agent for mitigating symptoms of cancer
WO1985001442A1 (en) * 1983-09-28 1985-04-11 Summa Medical Corporation Lectin composition and method for diagnosis of cancer
FR2618678A1 (en) * 1987-07-31 1989-02-03 Bensussan Emile Pharmaceutical composition for the treatment of inflammations of the buccal cavity
JPH0253717A (en) 1988-08-18 1990-02-22 Momotani Jiyuntenkan:Kk Dentifrice or mouth wash
JP2888554B2 (en) * 1989-09-20 1999-05-10 三井農林株式会社 Mycoplasma infection preventive agent
JPH0441435A (en) * 1990-06-06 1992-02-12 Yasumasa Iwamoto Herbal tea and production thereof
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
JP3242997B2 (en) 1992-06-25 2001-12-25 三井農林株式会社 Hyaluronidase activity inhibitor
JP2732504B2 (en) * 1995-03-08 1998-03-30 農林水産省中国農業試験場長 Arachidonic acid metabolic activity inhibitor and its production method
IT1275905B1 (en) * 1995-03-14 1997-10-24 Indena Spa POLYPHENOLIC FRACTIONS OF TEA, THEIR USE AND FORMULATIONS THAT CONTAIN THEM
JPH09176009A (en) * 1995-12-27 1997-07-08 Inahata Koryo Kk New antimutagenic agent and substance having antimutagenic action
JPH09227374A (en) 1996-02-28 1997-09-02 Taiyo Kagaku Co Ltd Composition for inhibiting production of stress protein
DE19627344A1 (en) 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutic composition containing epicatechin and/or theaflavin
DE29623606U1 (en) * 1996-07-01 1999-06-10 Vitasyn Gmbh Entwicklung & Ver Therapeutically effective or health-promoting preparation from defined polyphenol compounds from green tea extract
JPH1072361A (en) 1996-09-02 1998-03-17 Itouen:Kk Tnf-producing depressant from tea leaf extract
JPH10175874A (en) 1996-12-19 1998-06-30 Suntory Ltd Antiallergic agent
CH692837A5 (en) 1997-07-02 2002-11-29 Lisapharma Spa A pharmaceutical composition for use in foodstuffs, dietetic or medicinal product suitable to improve the oral absorption of the polyphenols and particularly of resveratrol present in grapes and in its p
WO1999008693A1 (en) 1997-08-14 1999-02-25 Joel Howard Glass Method for extracting synergistic and biological activity maintaining compound from camellia sinensis; an extracted compound and use of said compound in the food processing or pharmaceutical industry
CN1194790A (en) * 1997-09-09 1998-10-07 张永明 Tea for prolonging life
JP3497362B2 (en) * 1997-11-12 2004-02-16 株式会社朝日商事 Anticancer drugs
US6008260A (en) * 1998-01-09 1999-12-28 Pharmascience Cancer chemopreventative composition and method
AU4043900A (en) * 1999-03-30 2000-10-16 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
DE29908634U1 (en) 1999-04-09 1999-12-16 Hoensch Harald Food supplements for the treatment of intestinal diseases
EP1207862A2 (en) 1999-06-07 2002-05-29 The University Of Sheffield Arthritis treatment
AU776783B2 (en) 1999-07-09 2004-09-23 Sun Farm Corporation Method of treating malignancies and viral infections and improving immune function with a dietary supplement
AU7596100A (en) 1999-09-21 2001-04-24 Rutgers, The State University Resveratrol analogs for prevention of disease
CA2383224C (en) * 1999-09-21 2010-12-07 Geetha Ghai Extracts of orange peel for prevention and treatment of cancer
US6264995B1 (en) * 1999-10-19 2001-07-24 Thomas Newmark Herbal composition for reducing inflammation and methods of using same
FI20000004A0 (en) 2000-01-03 2000-01-03 Slk Foundation Flavonoidilääke ...

Also Published As

Publication number Publication date
US20020146472A1 (en) 2002-10-10
WO2002039956A3 (en) 2003-02-20
CA2431196A1 (en) 2002-05-23
EP1349560B1 (en) 2012-07-11
WO2002039956A2 (en) 2002-05-23
EP1349560A2 (en) 2003-10-08
EP1349560A4 (en) 2008-02-20
US7238376B2 (en) 2007-07-03
CA2431196C (en) 2012-01-24
US20040224034A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
AU2002217832A1 (en) Black tea extract for prevention of disease
AU5041000A (en) An effervescent green tea extract formulation
HUP0300853A3 (en) Hard capsule
AU2001246538A1 (en) Black tea manufacture
AU6030299A (en) Oral compositions comprising tea polyphenol
EP1365657B8 (en) Black tea manufacture
EP2382877B8 (en) Green tea extract
AU2000278445A1 (en) Tea catechin formulations and processes for making same
AUPQ504300A0 (en) Extraction of flavonoids
AU2001262691A1 (en) Cosmetic preparation
AU2002221594A1 (en) Magazine for capsules of espresso coffee
HUP0302462A3 (en) Soluble black coffee
AU5216701A (en) Cold water soluble tea
GB2350047B (en) Black tea manufacture
AU2000259752A1 (en) Method of obtaining a tea pigment from tea leaves
AU2001247196A1 (en) Methods and compositions for detection of disease
AU2002222148A1 (en) Preparation of spheroids
AU2348901A (en) Use of an extract from plantago lanceolata
AU2000243264A1 (en) Human nim1 kinase
AU2000241467A1 (en) Cognitive enhancer comprising ginseng extract
AU2001285882A1 (en) Non-bitter chicory extract
AU2002213750A1 (en) The uses of chinese herb piper laetispicum c. dc and its extract for the preparation of pharmaceutical composition
AU1578400A (en) Pepper extract
AU2000236545A1 (en) Extract for abstaining from narcotics and its preparation
AU1386400A (en) Extract